Get started
Author

Tomáš Vařeka

Observed names: T Vareka, T. Vareka, T. Vařeka, Tomas Vareka, Tomás Vareka
Institution: Charles University
ORCID: 0000-0001-5390-8272
Observed ORCID: 0000-0001-5390-8272
OpenAlex ID: A5017232103
Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population
2012 · Helena Buzkova, Kristina Pechandova, et al. · Medical Science Monitor · 29
PDF
The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic
2014 · Karel Dvorak, Radvan Hainer, et al. · Biomedical Papers · 16
PDF
Plasma fatty acid profile in depressive disorder resembles insulin resistance state.
2012 · Tomas Vareka, Marek Vecka, et al. · PubMed · 9
Ms247 Leptin, Adiponectin and Leptin to Adiponectin Ratio in Depressive Women
2010 · M. Zeman, R. Jirák, et al. · Atherosclerosis Supplements · 6
[Statin-ezetimibe combination in hyperlipidemia treatment].
2012 · Tomás Vareka, Daniela Vítková, et al. · PubMed · 1
Ms256 Features of Metabolic Syndrome in Depressive Disorder
2010 · T. Vařeka, M. Zeman, et al. · Atherosclerosis Supplements · 1
[Shy-Drager syndrome].
2010 · Magdaléna Dusejovská, Tomás Vareka, et al. · PubMed · 1
[Oxidation stress, insulin resistance and endothelial dysfunction during the treatment of hyperlipidaemia].
2006 · M Zeman, M Vecka, et al. · PubMed · 1
Žák s diabetes mellitus 1. typu v tělesné výchově (1. část)
2014 · Jitka Vařeková, Klára Daďová, et al.
Žák s diabetes mellitus v tělesné výchově (II. část)
2014 · Klára Daďová, Jitka Vařeková, et al.
Ortostatická hypotenze u Shyova-Dragerova syndromu
2010 · Tomáš Vařeka, Magdaléna Dušejovská, et al. · Interní medicína pro praxi
Adiponectin-leptin Ratio Is Decreased in Metabolic Syndrome
2008 · T. Vareka, M. Zeman, et al. · Atherosclerosis Supplements
Po21-686 Conjugated Dienes Concentrations Discriminate Persons With Metabolic Syndrome
2007 · M. Zeman, M. Vecka, et al. · Atherosclerosis Supplements
Th-P16:269 Indices of oxidative stress and inflammation during the statin-fibrate combination treatment
2006 · T. Vareka, M. Vecka, et al. · Atherosclerosis Supplements
W16-P-093 N-3 Fatty acids, composition of VLDL and LDL, homocysteine and microalbuminuria in diabetic dyslipidemia,treated with statin-fibrate combination
2005 · M. Zeman, A. ák, et al. · Atherosclerosis Supplements
[Diabetic gangrene as the prime manifestation of diabetes mellitus].
2004 · T Vareka, J Zapletalová, et al. · PubMed
Works count: 16
Citation count: 64
H-index: 4
I10-index: 2
Year
Topic
Type